Tom E. Callis

Author of 2 Presentation(s)

13. Heart Failure and Cardiomyopathies: Clinical 902-08

902-08 - CARDIOLOGISTS BEWARE: CLINICAL LIMITATIONS OF GENOTYPING- VERSUS SEQUENCING-BASED STRATEGIES FOR CARDIOMYOPATHY EVALUATION

Session
902 - Highlighted Original Research: Heart Failure and Cardiomyopathies and the Year in Review
Speakers
Pathway
13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number
902-08
Presentation Rating
 4
13. Heart Failure and Cardiomyopathies: Clinical 1205-141

1205-141 - PRECISION MEDICINE OPPORTUNITIES FOR FAMILIAL ARRHYTHMIAS AND CARDIOMYOPATHIES IDENTIFIED WHEN COST OF GENETIC TESTING IS REMOVED AS A BARRIER

Session
1205 - Heart Failure and Cardiomyopathies: Clinical 3
Speakers
Pathway
13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number
1205-141
Presentation Rating
 3

Author of 1 Presentation

13. Heart Failure and Cardiomyopathies: Clinical 902-08

902-08 - CARDIOLOGISTS BEWARE: CLINICAL LIMITATIONS OF GENOTYPING- VERSUS SEQUENCING-BASED STRATEGIES FOR CARDIOMYOPATHY EVALUATION (ID 3700)

Session
902 - Highlighted Original Research: Heart Failure and Cardiomyopathies and the Year in Review
Speakers
Pathway
13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number
902-08
Presentation Rating
 4

Author of 1 Presentation

13. Heart Failure and Cardiomyopathies: Clinical 1205-141

1205-141 - PRECISION MEDICINE OPPORTUNITIES FOR FAMILIAL ARRHYTHMIAS AND CARDIOMYOPATHIES IDENTIFIED WHEN COST OF GENETIC TESTING IS REMOVED AS A BARRIER

Session
1205 - Heart Failure and Cardiomyopathies: Clinical 3
Speakers
Pathway
13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number
1205-141
Presentation Rating
 3